Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Genomic imprinting, disrupted placental expression, and speciation.

Brekke TD, Henry LA, Good JM.

Evolution. 2016 Dec;70(12):2690-2703. doi: 10.1111/evo.13085. Epub 2016 Oct 28.

PMID:
27714796
2.

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Feinberg AP, Koldobskiy MA, Göndör A.

Nat Rev Genet. 2016 May;17(5):284-99. doi: 10.1038/nrg.2016.13. Epub 2016 Mar 14. Review.

3.

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.

Krepischi AC, Maschietto M, Ferreira EN, Silva AG, Costa SS, da Cunha IW, Barros BD, Grundy PE, Rosenberg C, Carraro DM.

Mol Cytogenet. 2016 Feb 24;9:20. doi: 10.1186/s13039-016-0227-y. eCollection 2016.

4.

Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival.

Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.

Clin Epigenetics. 2015 Oct 15;7:110. doi: 10.1186/s13148-015-0145-6. eCollection 2015.

5.

Microarray-based DNA methylation study of Ewing's sarcoma of the bone.

Park HR, Jung WW, Kim HS, Park YK.

Oncol Lett. 2014 Oct;8(4):1613-1617. Epub 2014 Jul 7.

6.

Abnormalities of the DNA methylation mark and its machinery: an emerging cause of neurologic dysfunction.

Weissman J, Naidu S, Bjornsson HT.

Semin Neurol. 2014 Jul;34(3):249-57. doi: 10.1055/s-0034-1386763. Epub 2014 Sep 5. Review.

7.

Vitamin D and the epigenome.

Fetahu IS, Höbaus J, Kállay E.

Front Physiol. 2014 Apr 29;5:164. doi: 10.3389/fphys.2014.00164. eCollection 2014. Review.

8.

Epigenetics: a new way to look at kidney diseases.

Beckerman P, Ko YA, Susztak K.

Nephrol Dial Transplant. 2014 Oct;29(10):1821-7. doi: 10.1093/ndt/gfu026. Epub 2014 Mar 27. Review.

9.

A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases.

Yang X, Gao L, Guo X, Shi X, Wu H, Song F, Wang B.

PLoS One. 2014 Jan 31;9(1):e87797. doi: 10.1371/journal.pone.0087797. eCollection 2014.

10.

CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.

Murphy AJ, Pierce J, de Caestecker C, Ayers GD, Zhao A, Krebs JR, Saito-Diaz VK, Lee E, Perantoni AO, de Caestecker MP, Lovvorn HN 3rd.

Oncotarget. 2014 Jan 30;5(2):386-402.

11.

Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.

Leick MB, Shoff CJ, Wang EC, Congress JL, Gallicano GI.

Am J Stem Cells. 2011 Aug 19;1(1):59-74. Print 2012.

12.

Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3.

Lui JC, Baron J.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6181-6. doi: 10.1073/pnas.1219079110. Epub 2013 Mar 25.

13.

Dynamic DNA methylation across diverse human cell lines and tissues.

Varley KE, Gertz J, Bowling KM, Parker SL, Reddy TE, Pauli-Behn F, Cross MK, Williams BA, Stamatoyannopoulos JA, Crawford GE, Absher DM, Wold BJ, Myers RM.

Genome Res. 2013 Mar;23(3):555-67. doi: 10.1101/gr.147942.112. Epub 2013 Jan 16.

14.

miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema.

Watson JA, Bryan K, Williams R, Popov S, Vujanic G, Coulomb A, Boccon-Gibod L, Graf N, Pritchard-Jones K, O'Sullivan M.

PLoS One. 2013;8(1):e53417. doi: 10.1371/journal.pone.0053417. Epub 2013 Jan 7.

15.

Mitochondria and cancer.

Wallace DC.

Nat Rev Cancer. 2012 Oct;12(10):685-98. doi: 10.1038/nrc3365. Review.

16.

Epigenetic regulation of gene expression in keratinocytes.

Botchkarev VA, Gdula MR, Mardaryev AN, Sharov AA, Fessing MY.

J Invest Dermatol. 2012 Nov;132(11):2505-21. doi: 10.1038/jid.2012.182. Epub 2012 Jul 5. Review.

17.

Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.

Bielen A, Box G, Perryman L, Bjerke L, Popov S, Jamin Y, Jury A, Valenti M, Brandon Ade H, Martins V, Romanet V, Jeay S, Raynaud FI, Hofmann F, Robinson SP, Eccles SA, Jones C.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1267-76. doi: 10.1073/pnas.1105034109. Epub 2012 Apr 23.

18.

Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin.

Diaz Perez SV, Kim R, Li Z, Marquez VE, Patel S, Plath K, Clark AT.

Hum Mol Genet. 2012 Feb 15;21(4):751-64. doi: 10.1093/hmg/ddr506. Epub 2011 Nov 4.

19.

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.

Maschietto M, Trapé AP, Piccoli FS, Ricca TI, Dias AA, Coudry RA, Galante PA, Torres C, Fahhan L, Lourenço S, Grundy PE, de Camargo B, de Souza S, Neves EJ, Soares FA, Brentani H, Carraro DM.

Cell Death Dis. 2011 Nov 3;2:e224. doi: 10.1038/cddis.2011.105.

20.

WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.

Perlman EJ, Grundy PE, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC, Ruteshouser EC, Huff V.

J Clin Oncol. 2011 Feb 20;29(6):698-703. doi: 10.1200/JCO.2010.31.5192. Epub 2010 Dec 28.

Supplemental Content

Support Center